ESMO 2020 Forward Looking Statement This presentation contains statements about the Companys future plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995.

Esmo 2020. Learn more about scientific developments and new research in oncology. COVID 19 - ESMO Highlights LATAM Impacts. European Society For Medical Oncology.

Abstracts are open access. ESMO Virtual Congress 2020. 19 Sep - 18 Oct 2020.

Phase 3 KEYNOTE-590 Trial. A 10-year single institutional experience. Access new data on Endometrial Cancer.

Presentations slides and webcasts are available to ESMO members and attendees according to the presenters agreement to release them. Accelerating Research to Practice. This phase III double-blind placebo-controlled randomized controlled trial assessed ipatasertib in combination with abiraterone acetate and steroid prednisone.

The ESMO Congress is the most influential oncology platform in Europe for clinicians researchers patient advocates journalists and the pharmaceutical industry from all over the world. Find resources from the Science Weekend. Efficacy and safety of abemaciclib in ABC supported phase III evaluation in the adjuvant setting.

Highlights Clinical debate QA. The ESMO 2020 Congress will take place from 18 to 22 September 2020 at the IFEMA Feria de Madrid Spain. Controversies in endometrial cancer.